Indee Labs
Scalable, non-viral hardware for gene deliveryIndee Labs
Indee Labs is developing a non-viral, intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes with minimal perturbation. The technology is used by global pharmaceutical and biotechnology companies as well as top universities. The Indee Labs team has demonstrated revolutionary improvements over existing intracellular delivery methods including scalability, high yield (i.e. recovery, viability and efficiency), negligible T-cell perturbation along with rapid processing of research-, clinical- and commercial-scale samples with a simple workflow and a small footprint.
Blog Posts
1st November, 2019
The Limitations & Challenges of Cancer Therapies
28th August, 2019
What is Microfluidic Vortex Shedding?
26th July, 2019
New Cell Contenders in the CAR Field (Part 2)
27th June, 2019
New Cell Contenders in the CAR Field (Part 1)
3rd June, 2019
The Problem with Gene-Modified Cell Therapy Manufacturing
Location
Sydney
Links
People
Founder
Founder